UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification

Journal of hematology and oncology, 2016-09, Vol.9 (1), p.78-78, Article 78

2016

Volltextzugriff (PDF)

Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility

European journal of haematology, 2021-09, Vol.107 (3), p.324-332

2021

Volltextzugriff (PDF)

Prevention of psychosocial morbidity and improvement of coping strategies: Effects of a cancer patient and caregiver centred information series

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e20566-e20566

2014

Volltextzugriff (PDF)

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

Annals of hematology, 2019-04, Vol.98 (4), p.897-907

2019

Volltextzugriff (PDF)

Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation

Annals of hematology, 2012-07, Vol.91 (7), p.1115-1120

2012

Volltextzugriff (PDF)

Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial

Hematological oncology, 2020-08, Vol.38 (3), p.244-256

2020

Volltextzugriff (PDF)

Surgical resection of urological tumor metastases following medical treatment

Deutsches Ärzteblatt international, 2012-09, Vol.109 (39), p.631-637

2012

Volltextzugriff (PDF)

A Phase 1, First-in-Human Study of AMG 176, a Selective MCL-1 Inhibitor, in Patients With Relapsed or Refractory Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e53-e54

2019

Volltextzugriff (PDF)

The 3-OH Derivative of the Polychlorinated Biphenyl (PCB)-28 Inhibits Telomerase Expression and Accelerates Telomere Shortening in Vitro: A Rationale for the Significantly Shortened Telomere Length Found in Peripheral Blood Lymphocytes of Workers Exposed to High Doses of Lower Chlorinated PCBs

Blood, 2014-12, Vol.124 (21), p.4139-4139

2014

Volltextzugriff (PDF)

Evidence for Premature Aging of (Clonal but also) Non-Clonal Hematopoietic Stem Cells in Patients with Acute Myeloid Leukemia (AML)

Blood, 2014-12, Vol.124 (21), p.1048-1048

2014

Volltextzugriff (PDF)

CpG island methylation patterns in chronic lymphocytic leukemia

Leukemia & lymphoma, 2009-01, Vol.50 (3), p.419-426

2009

Volltextzugriff (PDF)

Response and Overall Survival Is Impaired in Obese Patients with Acute Myelogenous Leukemia

Blood, 2012-11, Vol.120 (21), p.1522-1522

2012

Volltextzugriff (PDF)

Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma

Epigenetics, 2011-08, Vol.6 (8), p.1047-1052

2011

Volltextzugriff (PDF)

Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas

Blood, 2015-12, Vol.126 (23), p.3880-3880

2015

Volltextzugriff (PDF)

Quantitative analyses of DAPK1 methylation in AML and MDS

International journal of cancer, 2012-07, Vol.131 (2), p.E138-E142

2012

Volltextzugriff (PDF)

Abstract 3142: Hypermethylation of the tissue inhibitor of metalloproteinases-2 gene in multiple myeloma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3142-3142

2012

Volltextzugriff (PDF)

Identification of Atypical Plasma Cells in Patients with MGUS or Multiple Myeloma Through Expression of Immunoreceptor CD229

Blood, 2012-11, Vol.120 (21), p.4969-4969

2012

Volltextzugriff (PDF)

Telomere Shortening At Diagnosis Of Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Is Significantly More Pronounced In Patients With Less-Than-Optimal Versus Optimal Molecular Response (ELN criteria) After 12 Months Of Treatment With Nilotinib

Blood, 2013-11, Vol.122 (21), p.1471-1471

2013

Volltextzugriff (PDF)

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial

Blood, 2016-12, Vol.128 (22), p.1857-1857

2016

Volltextzugriff (PDF)

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

Blood, 2016-12, Vol.128 (22), p.185-185

2016

Volltextzugriff (PDF)

Activated fibronectin-secretory phenotype of mesenchymal stromal cells in pre-fibrotic myeloproliferative neoplasms

Journal of hematology and oncology, 2014-12, Vol.7 (1), p.92-92, Article 92

2014

Volltextzugriff (PDF)

Abstract 4815: Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4815-4815

2011

Volltextzugriff (PDF)

DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia

Clinical epigenetics, 2015-11, Vol.7 (117), p.116-116, Article 116

2015

Volltextzugriff (PDF)

Array‐based DNA methylation profiling in acute myeloid leukaemia

British journal of haematology, 2011-10, Vol.155 (1), p.65-72

2011

Volltextzugriff (PDF)

Friday leukemia: myth or reality?

Blood, 2010-01, Vol.115 (4), p.912-912

2010

Volltextzugriff (PDF)

26 – 50 von 64

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(63)
Tagungsberichte
(1)

Sprache

Englisch
(62)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification

Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility

Prevention of psychosocial morbidity and improvement of coping strategies: Effects of a cancer patient and caregiver centred information series

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation

Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial

Surgical resection of urological tumor metastases following medical treatment

A Phase 1, First-in-Human Study of AMG 176, a Selective MCL-1 Inhibitor, in Patients With Relapsed or Refractory Multiple Myeloma

The 3-OH Derivative of the Polychlorinated Biphenyl (PCB)-28 Inhibits Telomerase Expression and Accelerates Telomere Shortening in Vitro: A Rationale for the Significantly Shortened Telomere Length Found in Peripheral Blood Lymphocytes of Workers Exposed to High Doses of Lower Chlorinated PCBs

Evidence for Premature Aging of (Clonal but also) Non-Clonal Hematopoietic Stem Cells in Patients with Acute Myeloid Leukemia (AML)

CpG island methylation patterns in chronic lymphocytic leukemia

Response and Overall Survival Is Impaired in Obese Patients with Acute Myelogenous Leukemia

Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma

Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas

Quantitative analyses of DAPK1 methylation in AML and MDS

Abstract 3142: Hypermethylation of the tissue inhibitor of metalloproteinases-2 gene in multiple myeloma

Identification of Atypical Plasma Cells in Patients with MGUS or Multiple Myeloma Through Expression of Immunoreceptor CD229

Telomere Shortening At Diagnosis Of Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Is Significantly More Pronounced In Patients With Less-Than-Optimal Versus Optimal Molecular Response (ELN criteria) After 12 Months Of Treatment With Nilotinib

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

Activated fibronectin-secretory phenotype of mesenchymal stromal cells in pre-fibrotic myeloproliferative neoplasms

Abstract 4815: Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia

DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia

Array‐based DNA methylation profiling in acute myeloid leukaemia

Friday leukemia: myth or reality?

Aktive Filter

Suchergebnisse filtern